Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05116397
Other study ID # USARIEM
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 10, 2021
Est. completion date April 14, 2022

Study information

Verified date May 2022
Source United States Army Research Institute of Environmental Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this randomized, single-blind, placebo-controlled crossover trial is to determine the effects of graded hypercapnia (0, 2, and 4% inspired CO2) on endurance performance. Twelve healthy and fit young adults (men and women) will complete this study. Participants will perform experimental trials on 3 separate days (one each breathing 0%, 2%, and 4% inspired CO2-all with normal 21% oxygen). During each trial, they will perform 10 minutes of submaximal treadmill walking exercise and then complete a self-paced 2-mile treadmill run time-trial.


Description:

Participants will undergo baseline measurements of pulmonary function and maximal oxygen uptake (VO2max). They will then complete two familiarization trials, with 10 minutes of submaximal exercise (~40%VO2max) followed by a self-paced 2-mile treadmill time trial. Lastly, they will complete three experimental trials, repeating the same submaximal and time-trial exercise procedures while breathing the test gas (0%, 2%, or 4% CO2-all with normal 21% oxygen). During the experimental trials, arterialized capillary blood samples will be collected at rest breathing room air, at rest breathing the test gas, and during submaximal exercise at 40% VO2max breathing the test gas. The primary outcome is 2-mile treadmill time-trial performance. Secondary outcomes include ventilation, metabolic rate, heart rate, arterialized capillary pH/PCO2/HCO3, perceived exertion, dyspnea, leg discomfort, breathing descriptors, and headache ratings.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date April 14, 2022
Est. primary completion date April 14, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Male or female, age 18-45 - In good health as determined by medical screening - Passed his/her most recent Army Combat Fitness Test (ACFT) (Military Volunteers Only) or performs aerobic exercise at least 2 times per week and able to complete two mile run in = 21 minutes (Civilian Volunteers) - Willing to not participate in any exercise or drink alcoholic beverages for 24 hours before each study visit. - Willing to not take part in any strenuous exercise in the 36 hours before each visit. - Willing not to drink caffeine or eat food until after testing on familiarization and performance testing visits (visits 2-6). - Willing to maintain a similar dietary pattern in the 2 days before each familiarization and performance visits. - Have supervisor approval if permanent party military or a federal employee at U.S. Army Natick Soldier System Center - Able to speak and read English fluently Exclusion Criteria: - Females who are pregnant or planning to become pregnant during the study - Taking dietary supplements, prescriptions, or over the counter medication, other than a contraceptive (unless approved by medical staff & PI) - Musculoskeletal injuries that compromise ability to run on a treadmill - Abnormal blood count, presence of abnormal blood chemicals (hemoglobin S or sickle cell traits) - Smokers or tobacco/nicotine users (unless have quit > 1 month prior) - Any history of asthma - Current or recent respiratory tract or sinus infections (< 1 month prior) - Allergy to skin adhesive - Any history of migraine or recurrent headaches - Any history of panic disorder - Blood donation in the previous 8 weeks - Positive Covid-19 test within the last month

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Inspired gas
Inspired gas content

Locations

Country Name City State
United States USARIEM Natick Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
United States Army Research Institute of Environmental Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary 2 mile self-paced treadmill time trial performance Time to complete self-paced 2 mile treadmill time trial (min:sec) 30 minutes
Secondary Ventilation rate Ventilation rate will be assessed using a pneumotachometer [L/min] 30 minutes
Secondary Oxygen consumption Oxygen consumption will be assessed using computerized indirect calorimetry [ml/kg/min] 30 minutes
Secondary Heart rate Heart rate will be assessed using telemetry [beats per min] 30 minutes
Secondary Arterialized capillary pH Arterialized capillary pH will be assessed using a blood gas analyzer [Unitless] 30 minutes
Secondary Arterialized capillary pCO2 Arterialized capillary pCO2 will be assessed using a blood gas analyzer [mmHg] 30 minutes
Secondary Arterialized capillary HCO3 Arterialized capillary HCO3 will be assessed using a blood gas analyzer [mEq/L] 30 minutes
Secondary Rating of perceived exertion Rating of perceived exertion will be assessed using Borg's 6-20 scale [AU] 30 minutes
Secondary Dyspnea Rating of perceived dyspnea will be assessed using Borg's 0-10 scale [AU] 30 minutes
Secondary Leg discomfort Rating of perceived leg discomfort will be assessed using Borg's 0-10 scale [AU] 30 minutes
Secondary Headache Headache will be assessed using a visual analog scale [AU] 30 minutes
Secondary Breathing descriptors Breathing descriptors will be assessed by having participants check statements that apply to their breathing (e.g., breathing out requires more effort) [unitless] 30 minutes
See also
  Status Clinical Trial Phase
Completed NCT02917668 - Evaluation of the Risk of Hyperoxia-induced Hypercapnia in Obese Cardiac Surgery Patients N/A
Terminated NCT02801162 - Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard N/A
Completed NCT02429154 - Assessment of Cerebral Vasoreactivity Using Near-infrared Spectroscopy (NIRS) in Infants (VARO) N/A
Not yet recruiting NCT02201875 - Intrinsic Periodic Pattern of Breathing N/A
Completed NCT02068274 - CO2 Monitoring Study N/A
Completed NCT01898858 - Effects of O2 and/or CO2 Inhalation on Rest and Exercise Pulmonary Hemodynamic N/A
Completed NCT00006318 - Role of Prostaglandins in the Regulation of Brain Blood Flow N/A
Completed NCT00001845 - Study of Brain Blood Flow During Induced Hypercapnia (Excess Blood Carbon Dioxide) N/A
Completed NCT03221387 - Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients N/A
Completed NCT05470465 - Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation Phase 1
Recruiting NCT05505279 - Ventilatory Effects of THRIVE During EBUS Phase 3
Completed NCT04497090 - Adaptive Non-invasive Ventilation to Abolish Tidal Flow Limitation N/A
Completed NCT01882257 - Home-Based Diagnosis and Management of Sleep-Related Breathing Disorders in Spinal Cord Injury N/A
Terminated NCT00710541 - Non-invasive Ventilation in Severe Chronic Obstructive Pulmonary Disease(COPD) N/A
Completed NCT05189158 - Ventilatory Responses to Hypercapnic and Hypoxic Conditions in Hyperventilants N/A
Completed NCT04409470 - Venous Versus Arterial Blood Gas Sampling in Undifferentiated Emergency Patients
Completed NCT04512781 - Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Cannulae Designs N/A
Recruiting NCT03741998 - Nasopharyngeal Airway Facilitate Transnasal Humidified Rapid Insufflation Ventilatory Exchange N/A
Recruiting NCT05761756 - Oxygen Toxicity: Mechanisms in Humans N/A
Recruiting NCT02980770 - Postoperative Complications in Patients With Obesity Hypoventilation Syndrome N/A